Connect with us

Subscribe

Subscribe

News & Views

Do the vaccinations we have been encouraged to take contain pathogens and chemicals that could affect us in the future?

BY STEVEN KASZAB

In a time when healthcare providers face heavy financial pressures, ensuring they get paid for the right work at the right rates is essential. The onslaught of COVID-19 testing, and treatment has added many hurdles in the form of new codes, which are needed to ensure all health providers are paid. These codes are used to identify present and past patients also.

The CDC, AMA and CMS have issued guidelines to all insurance, and healthcare providers involved in the treatment of COVID-19. The agencies involved have worked to make COVID-19 medical codes readily available while fast tracking documentation guidelines for suspected and confirmed cases.

ICD-10-CM codes: Information readily available

  1. Confirmed cases positive, presumed positive
  2. Potential cases…suspected possible, probable or inclusive tests
  3. Ruled out cases
  4. Asymptomatic screening of those with negative or unknown results

Current Procedural Terminology (CPT) codes

  1. Nucleic Acid Testing: Testing of novel coronavirus
  2. Antibody Testing: revised code (86318 can be used along with new child code 86328 for antibody testing

Healthcare Common Procedure Coding System created for use with coronavirus testing

  1. CDC Testing for tests performed at CDC Labs
  2. Other testing done in non-CDC labs including private labs
  3. High DNA testing used in nucleic acid testing
  4. Other testing using tests of another technique other than the CDC Lab

Correct coding matters, for financial and healthcare purposes, faster reimbursements for testing and enabling patients to receive covered care. Accurate documentation supplies crucial data to be shared with appropriate medical authorities, which hopefully helps track the prevalence and spread of COVID-19 and other possibly new coronavirus.

The huge effort having been invested to track and document the fight against COVID-19 has presented society with a number of moral questions. Can the information acquired upon our citizenry be illegally used, manipulated and even stolen for nefarious uses? Do the multiple vaccinations we have been encouraged to take contain pathogens and chemicals that could affect us in the future? Are we guinea pigs, and has the pharmaceutical industry’s outreach to our governments become intertwined, controlling with undue influence present?

Ultimately research into the effects of multiple vaccinations and its long-term effects upon patients is essential. What is the ethical challenge before Big Pharma and our governments?

Did you know that once you go to a doctor’s office and give blood samples, and it is sent to a laboratory for analysis, what happens to that blood? Who has a patent/ownership on that sample of DNA? Did you know that multiple members of Big Pharma have taken samples of DNA and placed patents upon them, often for use in research and industry without the knowledge or approval of donors?

When a crisis happens, someone always sees an opportunity within the crisis, and profits from it. Has the pandemic created the perfect environment for such actions by our government and big business?

Newsletter Signup

Stay in the loop with exclusive news, stories, and insights—delivered straight to your inbox. No fluff, just real content that matters. Sign up today!

Written By

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Why LGBTQ youth still hurt

News & Views

Why sleep matters more than students think

Junior Contributors

Why Hamilton’s “Precious Metals” Is the most emotionally intelligent exhibit you will experience this year

Likes & Shares

Canada’s Housing Crisis: Why supply, not foreign buyers, is the core issue

Real Estate

Advertisement
Newsletter Signup

Stay in the loop with exclusive news, stories, and insights—delivered straight to your inbox. No fluff, just real content that matters. Sign up today!

Legal and Advertising Disclaimer: Advertisements, sponsored content, business listings and other promotional materials are supplied by third parties. Their publication does not constitute an endorsement, recommendation, representation, warranty or guarantee by TCN Now Inc. Advertisers and content providers are responsible for the accuracy, legality and substantiation of their claims and for obtaining all necessary copyright, trademark, privacy and other permissions. To the fullest extent permitted by law, TCN Now Inc., its directors, officers, employees, contractors and affiliates shall not be liable for any loss, damage, cost, expense or claim arising from third-party advertisements, products, services or promotional content. TCN Now Inc. reserves the right to refuse, edit, suspend or remove advertising or promotional content at its discretion. Editorial and Content Disclaimer: The opinions, commentary and viewpoints expressed in signed articles, columns, letters, guest submissions and other contributor content belong to the respective authors and do not necessarily reflect the opinions or views of TCN Now Inc., its directors, officers, employees, editors or affiliates. Content published by TCN Now Inc. is provided for general informational purposes only and is not intended as legal, financial, medical or other professional advice. While reasonable efforts are made to ensure accuracy, TCN Now Inc. does not guarantee that all information will be complete, current or free from error. To the fullest extent permitted by law, TCN Now Inc. disclaims liability for losses or claims arising from reliance upon contributor opinions, third-party submissions or general informational content. Copyright © 2026 TCN Now Inc. All rights reserved. Unless otherwise stated, the text, photographs, graphics, logos, designs and other original content appearing on this website are owned by or licensed to TCN Now Inc. and may not be copied, reproduced, republished, distributed, modified or commercially used without prior written permission, except as otherwise permitted by law. Third-party names, logos, trademarks and content remain the property of their respective owners.

Connect
Newsletter Signup

Stay in the loop with exclusive news, stories, and insights—delivered straight to your inbox. No fluff, just real content that matters. Sign up today!